Fady Ibraham Malik - May 6, 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
May 6, 2025
Transactions value $
-$48,820
Form type
4
Date filed
5/6/2025, 04:37 PM
Previous filing
Apr 22, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Malik Fady Ibraham EVP Research & Development 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO /s/ John O. Faurescu, attorney-in-fact for Dr. Malik 2025-05-06 0001551778

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $21.2K +2K +1.43% $10.60 142K May 6, 2025 Direct
transaction CYTK Common Stock Sale -$70K -2K -1.41% $35.01 140K May 6, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -2K -7.97% $0.00 23.1K May 6, 2025 Common Stock 2K $10.60 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).